Fariborz Mortazavi, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Dr. Mortazavi graduated the medical school from the Tehran University of Medical Sciences. He did his internship at the Mount Sinai Medical Center of Florida and completed his residency program at the St. Luke's Roosevelt Hospital Center. A fellowship followed at the University of Illinois College of Medicine soon after that. He is specialized in Medical Oncology and board certified in Hematology and Oncology. Dr. Mortazavi has been in practice for more than 11 years and is affiliated with the Ronald Reagan UCLA Medical Center and the St. John's Pleasant Valley Hospital. During his career, he has also contributed to 7 publications of medical interest.
Tehran University of Medical Sciences
Medical School
Mount Sinai Medical Center of Florida
Internship
St Luke's-Roosevelt Hospital Center
Residency
University of Illinois College of Medicine at Chicago
Fellowship
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
CA State Medical License: 2006 - 2017
American Board of Internal Medicine: Medical Oncology
American Board of Internal Medicine: Hematology
Ronald Reagan UCLA Medical Center
Languages: English/Spanish
(310) 825-9111
757 Westwood Plaza
Read MoreSt. John's Pleasant Valley Hospital
Languages: English/Spanish
(805) 389-5800
2309 Antonio Ave
Read MoreSt. John's Regional Medical Center
Languages: English/Spanish
(805) 988-2500
1600 N Rose Ave
Read MoreSt. Mary Medical Center Apple Valley
Languages: English/Spanish
(760) 242-2311
18300 California 18
Apple Valley, California 92307
CRK SH3N Domain Diminishes Cell Invasiveness of Non-Small Cell Lung Cancer.
Pezeshkpour, G. H.,Moatamed, F.,Lewis, M.,Hoang, B.,Rettig, M.,Mortazavi, F.; Genes Cancer. 2013 Oct 30.
See more >>PAK1 Kinase Promotes Cell Motility and Invasiveness through CRK-II Serine Phosphorylation in Non-Small Cell Lung Cancer Cells.
Rettig, M., Trinidad, K., Pezeshkpour, G., Frost, P., Sharma, S., Moatamed, F., Tamanoi, F., Mortazavi, F.; PLoS ONE. 2012.
See more >>c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells.
Mortazavi, F., Dubinett, S., Rettig, M.; Clin Exp Metastasis. 2011 Apr.
See more >>